Main Street Capital: A Good Choice To Navigate Concerns Of The BDC Sector
Seeking Alpha· 2025-05-16 01:10
I was lucky enough to initiate my starting position in Main Street Capital (NYSE: MAIN ) during the pandemic when shares were trading around $30 per share. Unfortunately, I didn't get the chance to accumulate the position size I wanted before shares tookFinancial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 15 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering high quality dividend stocks and ...
Fluent, Inc. (FLNT) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-16 01:08
Fluent, Inc. (NASDAQ:FLNT) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Don Patrick - CEO Ryan Perfit - CFO Conference Call Participants Maria Ripps - Canaccord Patrick Sholl - Barrington Research Bill Dezellem - Tieton Capital Management Operator Good afternoon, and welcome. Thank you for joining us to discuss Fluent's First Quarter 2025 Earnings Results. With me today are Fluent's Chief Executive Officer, Don Patrick; and Chief Financial Officer, Ryan Perfit. Our call toda ...
RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-16 01:07
RenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Valter Pinto - IR Ramtin Agah - Founder and Chief Medical Officer Shaun Bagai - CEO Ronald Kocak - VP Controller and Principal Accounting Officer Conference Call Participants Rafay Khalid - Ascendiant Capital Markets Operator Good afternoon, everyone, and welcome to the RenovoRx Q1 2025 Financial and Operational Highlights Conference Call. All participants will be in a listen-only mode. [Operator Instr ...
Omeros Corporation (OMER) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-16 01:07
Omeros Corporation (NASDAQ:OMER) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Williams - Investor and Media relations, Cook Williams Communications, Inc. Gregory Demopulos - Chairman & CEO David Borges - Chief Accounting Officer Nadia Dac - Chief Commercial Officer Conference Call Participants Steve Brozak - WBB Securities Operator Good afternoon, and welcome to today's earnings call for Omeros Corporation. At this time, all participants are in a listen-only mode. A ...
Warner Bros. Discovery, Inc. (WBD) MofafettNathanson 2025 Media, Internet & Communications Conference (Transcript)
Seeking Alpha· 2025-05-16 01:06
Warner Bros. Discovery, Inc. (NASDAQ:WBD) MofafettNathanson 2025 Media, Internet & Communications Conference May 15, 2024 3:10 PM ET Company Participants Gunnar Wiedenfels - Chief Financial Officer Conference Call Participants Robert Fishman - MoffettNathanson Robert Fishman So thank you. Gunnar Wiedenfels, obviously, CFO, Warner Bros. Discovery. We really appreciate you being here. You're going to bring our whole conference home for us, so thank you very much for coming tonight. Gunnar Wiedenfels Thank you ...
ECHOSTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating EchoStar Corporation on Behalf of EchoStar Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-16 01:00
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ:SATS) on behalf of EchoStar stockholders. Our investigation concerns whether EchoStar has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On May 12, 2025, The Wall Street Journal reported that the Federa ...
ELEVANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-16 01:00
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) in the United States District Court for the Southern District of Indiana on behalf of all persons and entities who purchased or otherwise acquired Elevance securities between April 18, 2024, and October 16, 2024, both dates inclusive (the “Class Period”). Investo ...
GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-16 01:00
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf of long-term stockholders following a class action complaint that was filed against Geron on March 14, 2025 with a Class Period from February 28, 2024 to February 25, 2025. Our investigation concerns whether the board of directors of Geron have breached their fiduciary duties to the company. The Compl ...
KYVERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-16 01:00
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) on behalf of long-term stockholders following a class action complaint that was filed against Kyverna on December 9, 2024 with a Class Period pursuant and/or traceable to the Company’s offering documents issued in connection with its initial public offering (“IPO”) conducted on February 8, 2024. Our in ...
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire· 2025-05-16 01:00
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that it granted stock options to purchase an aggregate of 461,000 shares of Tenaya common stock to three new non-executive employees in connection with the commencement of their employment. The stock options have an exerci ...